MAYWOOD, IL - While antibiotics have greatly reduced the dangers of ear infections, serious neurological complications, including hearing loss, facial paralysis, meningitis and brain abscess still occur, according to a report in the journal Current Neurology and Neuroscience Reports.
The article was written by Loyola Medicine otolaryngologists Michael Hutz, MD, Dennis Moore, MD, and Andrew Hotaling, MD.
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
The tool, a vaginal implant, decreases the number of cells that the HIV virus can target in a woman's genital tract. Unlike conventional methods of HIV prevention, such as condoms or anti-HIV drugs, the implant takes advantage of some people's natural immunity to the virus.
DARIEN, IL - April 16, 2018 - A position statement from the American Academy of Sleep Medicine (AASM) concludes that fatigue and sleepiness are inherent safety risks in the ridesharing industry.
In a study of more than 15,000 girls and their mothers -- all Kaiser Permanente members in Northern California -- maternal overweight and hyperglycemia were linked to the earlier onset of puberty in girls 6 to 11 years old. Early puberty has been linked to multiple adverse health developments as girls grow up.
DALLAS, April 16, 2018 -- African Americans who smoke appear to be at far greater risk of developing heart failure than those who never smoked, or those who quit, according to new research in the American Heart Association's journal Circulation.
Nearly 80 genes that could be linked to depression have been discovered by scientists.
The findings could help explain why some people may be at a higher risk of developing the condition, researchers say.
The study could also help researchers develop drugs to tackle mental ill-health, experts say.
Depression affects one in five people in the UK every year and is the leading cause of disability worldwide. Life events - such as trauma or stress - can contribute to its onset, but it is not clear why some people are more likely to develop the condition than others.
Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center offers a potential explanation for why the disease becomes chemoresistant, and a possible avenue to explore new diagnostic approaches.
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary and papillary thyroid, non-small cell lung, colorectal and bile duct cancers, which have been historically difficult to treat.
The hippocampus is an area of the brain commonly linked with memory and dementia.
But new U of T Scarborough research finds that it may also yield important clues about a range of mental health illnesses including addiction, anxiety and depression.
The research, authored by a team of neuroscientists, found that a specific part of the hippocampus could play an important role in emotional regulation, a finding that calls into question our understanding of how exactly this part of the brain works.
14 April 2018, Paris, France: Promising results for three drugs for the treatment of three rare liver diseases were presented today at The International Liver Congress™ 2018 in Paris, France. Sebelipase alfa, approved for treatment of lysosomal acid lipase (LAL) deficiency in 2015,24 showed sustained improvements and long-term tolerability in a diverse patient population.